Literature DB >> 23515832

Total knee arthroplasty for the management of joint destruction in tuberculous arthritis.

Yusuf Oztürkmen1, Onat Uzümcügil, Mahmut Karamehmetoğlu, Cem Leblebici, Mustafa Caniklioğlu.   

Abstract

PURPOSE: The purpose of this study was to evaluate our experience to clarify the suggestion that there should be a significant disease-free interval before total knee arthroplasty (TKA) and to determine the correct timing of surgery for reconstruction of the joint destruction in patients suffering from tuberculous arthritis.
METHODS: Twelve patients with advanced joint destruction and tuberculous arthritis of the knee with recent onset were reviewed in this study. The time interval from our diagnosis of active infection to arthroplasty averaged 4 ± 1.5 months. Histopathology of the biopsy specimens revealing granulomatous lesions, including epithelioid histiocytes surrounded by lymphocytes, confirmed the diagnosis of each patient. A primary knee prosthesis was performed in seven knees. In five knees, there was severe bone loss after the extensive debridement of the entire joint, and thereafter, revision prosthesis was preferred to preserve the joint line. Patients were given post-operative antituberculous treatment for a total of 1 year, whereas for three patients, whose erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) values remained above normal by the sixth month, the chemotherapy was continued for up to 18 months. The Knee Society TKA roentgenographic evaluation and scoring system was used for radiological evaluation of the knees. Clinical evaluation of the knees was done preoperatively and at the time of the most recent follow-up using the American Knee Society Scoring System.
RESULTS: Within the average follow-up period of 6.1 ± 1.8 years, no reactivation of tuberculous infection was found in any of the patients. ESR was normal, less than 20 mm/h, after a mean time of 5.5 ± 2.0 months. The CRP was normal, less than 0.8 mg/dl, after a mean time of 4.6 ± 1.3 months. At the most recent follow-up, the average knee score improved from 32.4 ± 19.4 to 83.4 ± 14.0 points (p < 0.05), and the average function score improved from 33.3 ± 11.9 to 86.6 ± 7.7 points (p < 0.05). Ten knees showed good integrity, and no radiolucent lines were found in the bone-prosthesis interface in relation to any component. Radiolucent lines were apparent on the tibial side in two knees. They were less than 1 mm thick and non-progressive, and clinically, there was no evidence of loosening of the component. Culture specimens were positive for five patients.
CONCLUSIONS: TKA is a safe procedure for tuberculous arthritis with recent onset providing symptomatic relief, functional improvement and early return to activity when performed in correct time. A long disease-free interval should not be a prerequisite for arthroplasty. Wide surgical debridement is the mainstay to eradicate the disease, and post-operative antituberculous chemotherapy controls the residual foci. LEVEL OF EVIDENCE: IV.

Entities:  

Mesh:

Year:  2013        PMID: 23515832     DOI: 10.1007/s00167-013-2473-4

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  38 in total

1.  Total knee arthroplasty in the presence of active tuberculosis.

Authors:  D W Gale; M L Harding
Journal:  J Bone Joint Surg Br       Date:  1991-11

2.  Arthroplasty for old tuberculosis of the knee.

Authors:  A Eskola; S Santavirta; Y T Konttinen; K Tallroth; S T Lindholm
Journal:  J Bone Joint Surg Br       Date:  1988-11

Review 3.  Prosthetic joint infection due to Mycobacterium tuberculosis: report of three cases.

Authors:  J I Tokumoto; S E Follansbee; R A Jacobs
Journal:  Clin Infect Dis       Date:  1995-07       Impact factor: 9.079

Review 4.  Chemotherapy for osteoarticular tuberculosis.

Authors:  Ashok Shembekar; Sudhir Babhulkar
Journal:  Clin Orthop Relat Res       Date:  2002-05       Impact factor: 4.176

5.  Immediate cementless total hip arthroplasty for the treatment of active tuberculosis.

Authors:  Taek Rim Yoon; Sung Man Rowe; Setyagung Budi Santosa; Sung Taek Jung; Jong Keun Seon
Journal:  J Arthroplasty       Date:  2005-10       Impact factor: 4.757

Review 6.  Delayed periprosthetic tuberculosis after total knee replacement: is conservative treatment possible?

Authors:  Devdatta Suhas Neogi; Ashok Kumar; Chandra Shekhar Yadav; Saurabh Singh
Journal:  Acta Orthop Belg       Date:  2009-02       Impact factor: 0.500

7.  Infection of total hip prosthesis by Mycobacterium tuberculosis and Mycobacterium chelonae in a patient with rheumatoid arthritis.

Authors:  Alex Brown; Peter Grubbs; Anne-Barbara Mongey
Journal:  Clin Rheumatol       Date:  2007-11-23       Impact factor: 2.980

8.  Reactivation of ancient joint tuberculosis of the knee following total knee arthroplasty after 61 years: a case report.

Authors:  J de Haan; A W J Vreeling; G G van Hellemondt
Journal:  Knee       Date:  2008-06-02       Impact factor: 2.199

9.  Total hip replacement in active advanced tuberculous arthritis.

Authors:  A S Sidhu; A P Singh; A P Singh
Journal:  J Bone Joint Surg Br       Date:  2009-10

10.  Evaluation of clinico-radiological, bacteriological, serological, molecular and histological diagnosis of osteoarticular tuberculosis.

Authors:  Anil K Jain; Santosh Kumar Jena; M P Singh; I K Dhammi; V G Ramachadran; Geeta Dev
Journal:  Indian J Orthop       Date:  2008-04       Impact factor: 1.251

View more
  9 in total

1.  The adductor tubercle: an important landmark to determine the joint line level in revision total knee arthroplasty.

Authors:  Francesco Iacono; Giovanni Francesco Raspugli; Giuseppe Filardo; Danilo Bruni; Stefano Zaffagnini; Simone Bignozzi; Mirco Lo Presti; Ibrahim Akkawi; Maria Pia Neri; Maurilio Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-03-12       Impact factor: 4.342

2.  A persistent case of tuberculosis of the pubic symphysis and pubic bone.

Authors:  Ulrike Dapunt; Alexander Mischnik; Stephan Goeppinger; Burkhard Lehner
Journal:  BMJ Case Rep       Date:  2014-03-10

3.  Total knee arthroplasty in advanced tuberculous arthritis of the knee.

Authors:  Min Zeng; Jie Xie; Long Wang; Yihe Hu
Journal:  Int Orthop       Date:  2015-11-18       Impact factor: 3.075

4.  Tuberculosis of the Knee: A Case Report and Literature Review.

Authors:  Francesco M Uboldi; Silvia Limonta; Paolo Ferrua; Andrea Manunta; Antonio Pellegrini
Journal:  Joints       Date:  2017-08-11

5.  Two-stage revision arthroplasty for Mycobacterium Tuberculosis periprosthetic joint infection: An outcome analysis.

Authors:  Chih-Hsiang Chang; Chih-Chien Hu; Yuhan Chang; Pang-Hsin Hsieh; Hsin-Nung Shih; Steve Wen-Neng Ueng
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

Review 6.  Arthroscopic treatment of Mycobacterium massiliense septic arthritis outbreak after intra-articular injection: A case-series report and literature review.

Authors:  Byung Ill Lee; Byung-Woong Jang; Hyung Suk Choi; Jeong Seok Lee; Yong Beom Kim
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

7.  Unconstrained one-stage total knee arthroplasty PS design in patient with secondary osteoarthritis due to granulomatous infection with medial femoral condyle defect: A case report.

Authors:  Nur Rahmansyah; Dicky Mulyadi; Raden Moechammad Satrio Nugroho Magetsari; Aditya Fuad Robby Triangga
Journal:  Int J Surg Case Rep       Date:  2022-07-30

8.  Knee arthrodesis using a unilateral external fixator combined with crossed cannulated screws for the treatment of end-stage tuberculosis of the knee.

Authors:  Xin Tang; Jing Zhu; Qi Li; Gang Chen; Weili Fu; Jian Li
Journal:  BMC Musculoskelet Disord       Date:  2015-08-19       Impact factor: 2.362

9.  Total Knee Arthroplasty in Patients with Unsuspected Tuberculosis of the Joint: A Report of Four Cases and a Systematic Review of the Literature.

Authors:  Du Wang; Xiao-Tang Sun; Chao-Fan Zhang; Xin-Yu Fang; Zi-da Huang; Qing-Cong Zheng; Wen-Ming Zhang
Journal:  Orthop Surg       Date:  2020-11-04       Impact factor: 2.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.